We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+27.66%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$16.6M
Cap. Flow
-$12.7M
Cap. Flow %
-8.29%
Top 10 Hldgs %
60.22%
Holding
56
New
20
Increased
9
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
AMRI
Albany Molecular Research Inc
AMRI
+$6.17M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.47M
3
PFE icon
Pfizer
PFE
+$3.14M
4
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
+$2.09M
5
SNY icon
Sanofi
SNY
+$1.27M

Top Sells

Rank Stock Value
1
ANIP icon
ANI Pharmaceuticals
ANIP
+$9.34M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$8.69M
3
FRX
FOREST LABORATORIES INC
FRX
+$4.22M
4
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$4.11M
5
GSK icon
GSK
GSK
+$2.45M

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.67%
2 Healthcare 35.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIN
51
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-50,000
Closed -$559K
SGNT
52
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-58,722
Closed -$1.49M
XNPT
53
DELISTED
XENOPORT, INC.
XNPT
– –
-77,000
Closed -$443K
FRX
54
DELISTED
FOREST LABORATORIES INC
FRX
– –
-70,382
Closed -$4.22M
GIVN
55
CALL
DELISTED
GIVEN IMAGING LTD
GIVN
– –
-100,000
Closed -$3.01M
CRTX
56
CALL
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
– –
-50,000
Closed -$475K
1 2
3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2014 Portfolio in Review

As of Q1 2014, Healthcare Value Capital held 56 positions worth $153M, up 12% from $136M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Healthcare Value Capital withdrew a net $12.7M in Q1 2014, closing 11 positions and reducing 10 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $4.22M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, up from 61% a quarter earlier, followed by Healthcare.

Against the trend, Healthcare Value Capital opened a new position in Albany Molecular Research Inc worth $8.33M.

  • Healthcare Value Capital's largest Q1 2014 buy was Albany Molecular Research Inc: 448,200 shares worth $8.33M.
  • Healthcare Value Capital added most to Teva Pharmaceuticals in Q1 2014, an estimated $3.47M increase.
  • Healthcare Value Capital's biggest Q1 2014 reduction was ANI Pharmaceuticals, cutting an estimated $9.34M.
  • Healthcare Value Capital fully exited FOREST LABORATORIES INC in Q1 2014, selling an estimated $4.22M.
  • Healthcare Value Capital's ten largest holdings make up 60% of its $153M portfolio in Q1 2014.
  • Healthcare Value Capital opened 20 new positions and closed 11 in Q1 2014.
  • Healthcare Value Capital's portfolio value rose 12% quarter-over-quarter to $153M.

Based on Healthcare Value Capital's 13F filing for Q1 2014, filed 13 May 2014.